FINIRAB Trademark

Trademark Overview


On Friday, November 10, 2023, a trademark application was filed for FINIRAB with the United States Patent and Trademark Office. The USPTO has given the FINIRAB trademark a serial number of 98264135. The federal status of this trademark filing is REGISTERED as of Tuesday, August 27, 2024. This trademark is owned by Sanofi Pasteur. The FINIRAB trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for human use
finirab

General Information


Serial Number98264135
Word MarkFINIRAB
Filing DateFriday, November 10, 2023
Status700 - REGISTERED
Status DateTuesday, August 27, 2024
Registration Number7488990
Registration DateTuesday, August 27, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 11, 2024

Trademark Statements


Goods and ServicesVaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 12, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSanofi Pasteur
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressLyon 69007
FR

Party NameSanofi Pasteur
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLyon 69007
FR

Party NameSanofi Pasteur
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLyon 69007
FR

Trademark Events


Event DateEvent Description
Tuesday, November 14, 2023NEW APPLICATION ENTERED
Thursday, May 9, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 22, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 12, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 2, 2024ASSIGNED TO EXAMINER
Tuesday, June 11, 2024PUBLISHED FOR OPPOSITION
Tuesday, August 27, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, August 27, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 11, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Related Keywords


finirab human vaccines